Skip to main content

Advertisement

SpringerLink
Log in

Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

The aim of our study was to examine the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) treatment on depressive symptoms, changes in bleeding patterns, and quality of life (QoL) among premenopausal women in our clinic.

Materials and methods

We recruited 120 premenopausal women, aged 18–50 years, who had sought care in the previous year for menorrhagia. LNG-IUS was inserted into eligible patients after the relevant evaluations. Both questionnaires were administered at time of the initial screening before and 6 months after insertion of the LNG-IUS. All patients completed the 36-item Short-Form Health Survey (SF-36) for QoL and Beck’s Depression Inventory for depressive symptoms.

Results

At the 6-month follow-up visit, the pictorial blood assessment chart score (PBAC) considerably decreased (p < 0.001). For SF-36 scores, physical functioning, physical role limitations, emotional role limitations, bodily pain, vitality, and mental health scores improved significantly after treatment (p < 0.001). Depression scores showed no significant difference from baseline to 6 months (p = 0.375).

Conclusion

The LNG-IUS for the treatment of menorrhagia increases the QoL, and depression scores did not increase significantly in 6 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shapley M, Jordan K, Croft PR (2004) An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 54:359–363

    PubMed Central  PubMed  Google Scholar 

  2. Coulter A, Peto V, Jenkinson C (1994) Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 11:394–401

    Article  CAS  PubMed  Google Scholar 

  3. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A et al (2001) Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357:273–277

    Article  CAS  PubMed  Google Scholar 

  4. National Institute for Health and Care Excellence (NICE) (2007) Heavy menstrual bleeding: full clinical guideline 44. NICE, London. Available from: http://www.nice.org.uk/nicemedia/live/11002/30401/30401.pdf

  5. Cote I, Jacobs P, Cumming D (2002) Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 100:683–687

    Article  PubMed  Google Scholar 

  6. Hallberg L, Hogdahl AM, Nilsson L, Rybo G (1966) Menstrual blood loss and iron deficiency. Acta Med Scand 180:639–650

    Article  CAS  PubMed  Google Scholar 

  7. Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A (1991) Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 98:789–796

    Article  CAS  PubMed  Google Scholar 

  8. Bhattacharya S, Middleton LJ, Tsourapas A, Lee AJ, Champaneria R, Daniels JP et al (2011) Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess 15(19):1–252 iii–xvi

    Google Scholar 

  9. Marjoribanks J, Lethaby A, Farquhar C (2006) Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev (2):CD003855

  10. National Advisory Committee on Health and Disability (1998) Guidelines for the management of heavy menstrual bleeding. New Zealand: NACHD

  11. Lethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev (4):CD002126

  12. Higham JM, O’Brien PM, Shaw RW (1990) Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97:734–739

    Article  CAS  PubMed  Google Scholar 

  13. Beck AT, Beck RW (1972) Screening depressed patients in family practice. A rapid technic. Postgrad Med 52(6):81–85

    CAS  PubMed  Google Scholar 

  14. Ware JE (1993) SF-36 health survey: manual and interpretation guide. New England Medical Center, Boston

    Google Scholar 

  15. Jenkinson C, Peto V, Coulter A (1994) Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia. Qual Life Res 3:317–321

    Article  CAS  PubMed  Google Scholar 

  16. Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance United States, 1994–1999. MMWR CDC Surveill Summ 51:1–8

    Google Scholar 

  17. Clarke A, Black N, Rowe P, Mott S, Howie K (1995) Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study. Br J Obstet Gynaecol 102:611–620

    Article  CAS  PubMed  Google Scholar 

  18. Middleton LJ, Champaneria R, Daniels JP, Bhattacharya S, Cooper KG, Hilken NH et al (2010) Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena®) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 341:c3929

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Luukkainen T (2000) The levonorgestrel intrauterine system: therapeutic aspects. Steroids 65:699–702

    Article  CAS  PubMed  Google Scholar 

  20. Andersson K, Batar I, Rybo G (1992) Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 46:575–584

    Article  CAS  PubMed  Google Scholar 

  21. Belhadj H, Sivin I, Diaz S et al (1986) Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 34:261–267

    Article  CAS  PubMed  Google Scholar 

  22. Higham JM, Shaw RW (1999) Clinical associations with objective menstrual blood volume. Eur J Obstet Gynecol Reprod Biol 82(1):73–76

    Article  CAS  PubMed  Google Scholar 

  23. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J (2004) Clinical outcomes and costs with the levonorgestrel releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow up. JAMA 291(12):1456–1463

    Article  CAS  PubMed  Google Scholar 

  24. Gemzell-Danielsson K, Inki P, Boubli L, O’Flynn M, Kunz M, Heikinheimo O (2010) Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)—a multicentre prospective study. Hum Reprod 25:354–359

    Article  CAS  PubMed  Google Scholar 

  25. Backman T, Huhtala S, Luoto R, Tuominen J, Rauramo I, Koskenvuo M (2002) Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol 99:608–613

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Selcuk University, Konya, Turkey

    Aybike Tazegül Pekin, Özlem Seçilmiş Kerimoğlu, Ayşe Gül Kebapcılar, Setenay Arzu Yılmaz, Nilgün Benzer & Çetin Çelik

Authors
  1. Aybike Tazegül Pekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Özlem Seçilmiş Kerimoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayşe Gül Kebapcılar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Setenay Arzu Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nilgün Benzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Çetin Çelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aybike Tazegül Pekin.

Additional information

Implications: The LNG-IUS not only corrects some of the physical problems experienced by patients who have unwanted irregular menstrual periods, namely menorrhagia, but also is effective in improving many psychological parameters, either directly or indirectly.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tazegül Pekin, A., Seçilmiş Kerimoğlu, Ö., Kebapcılar, A.G. et al. Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study. Arch Gynecol Obstet 290, 507–511 (2014). https://doi.org/10.1007/s00404-014-3237-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-014-3237-1

Keywords

Search

Navigation